Product Information |
DR-XY48708_PI_01.pdf
|
Registration Number |
DR-XY48708
|
Generic Name |
Dacomitinib (as monohydrate)
|
Brand Name |
Vizimpro
|
Dosage Strength |
45 mg
|
Dosage Form |
Film-Coated Tablet
|
Classification |
Prescription Drug (RX)
|
Pharmacologic Category |
Antineoplastic Agent (Epidermal Growth Factor Receptor (EGFR) Tyrosine kinase Inhibitor)
|
Packaging |
Alu-PA/Alu/PVC foil blister pack x 10's (Box of 30's) Alu-PA/Alu/PVC foil blister pack x 10's (Box of 10's) as Physician's Samples.
|
Manufacturer |
Pfizer Manufacturing Deutschland GMBH
|
Country of Origin |
Germany
|
Trader |
N/A
|
Importer |
Pfizer, Inc.
|
Distributor |
N/A
|
Application Type |
Monitored Release (MR) (Corrections)
|
Issuance Date |
13 February 2024
|
Expiry Date |
25 April 2028
|